• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症对高反应性血小板治疗-双重低反应(HTPR-DPR)患者纤维蛋白原周转率和止血平衡向促血栓形成状态重新分布的影响。

The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients.

机构信息

Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia, Faculty of Medicine in Katowice, Medical University of Silesia, Poniatowskiego Str 15, 40-055 Katowice, Poland.

Department of Anaesthesiology and Intensive Care, Upper-Silesian Medical Centre of the Silesian Medical University, Ziołowa 45, 40-635 Katowice, Poland.

出版信息

Mediators Inflamm. 2019 Jul 17;2019:3767128. doi: 10.1155/2019/3767128. eCollection 2019.

DOI:10.1155/2019/3767128
PMID:31396017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6664506/
Abstract

Knowledge about the influence of inflammation on platelet function and relocation of hemostatic balance to hypercoagulable state is still unclear. We compared two groups of patients who suffer from acute vs. chronic inflammatory process and additionally present high on-treatment platelet reactivity-dual platelet resistance. We did not found any differences in platelet aggregation between both investigated groups, but patients who suffer from chronic inflammation presented stronger relocation of the hemostatic balance to the hypercoagulability. A high concentration of prothrombin fragment F1+2 together with higher activity of von Willebrand factor in critical limb ischemia shows more exaggerated fibrinogen turnover although the blood concentration of this factor was in normal range. We concluded that high on-treatment platelet reactivity-dual platelet resistance and intensified inflammation are linked with elevated platelet and fibrinogen turnover to counteract proper hemostatic balance in favor of a prothrombotic state.

摘要

关于炎症对血小板功能和止血平衡向高凝状态转移的影响的知识仍不清楚。我们比较了两组患有急性和慢性炎症过程且同时存在高治疗后血小板反应性-双血小板抵抗的患者。我们没有发现两个研究组之间的血小板聚集有任何差异,但患有慢性炎症的患者止血平衡向高凝状态的转移更强烈。在严重肢体缺血中,凝血酶原片段 F1+2 浓度升高以及血管性血友病因子活性升高表明纤维蛋白原周转率更高,尽管该因子的血液浓度处于正常范围。我们得出结论,高治疗后血小板反应性-双血小板抵抗和炎症加剧与血小板和纤维蛋白原周转率升高有关,以对抗适当的止血平衡,有利于血栓形成状态。

相似文献

1
The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients.炎症对高反应性血小板治疗-双重低反应(HTPR-DPR)患者纤维蛋白原周转率和止血平衡向促血栓形成状态重新分布的影响。
Mediators Inflamm. 2019 Jul 17;2019:3767128. doi: 10.1155/2019/3767128. eCollection 2019.
2
Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.纤维蛋白原和血管性血友病因子在重建和免疫性血小板减少症中的血栓形成和血小板黏附中的差异作用。
Anesth Analg. 2011 May;112(5):1034-40. doi: 10.1213/ANE.0b013e318212fffc. Epub 2011 Apr 7.
3
Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?心房颤动与高凝状态:取决于临床因素还是/及基因改变?
J Thromb Thrombolysis. 2003 Dec;16(3):155-61. doi: 10.1023/B:THRO.0000024053.45693.fc.
4
Nonvalvular atrial fibrillation: evidence for a prothrombotic state.非瓣膜性心房颤动:血栓前状态的证据。
CMAJ. 1997 Sep 15;157(6):673-81.
5
Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.使用含有孕二烯酮或左炔诺孕酮的低剂量复方口服避孕药两年后对止血的影响。
Clin Appl Thromb Hemost. 1999 Jan;5(1):60-70. doi: 10.1177/107602969900500112.
6
Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.单纯性轻至中度高血压患者的内皮损伤与止血标志物及其与危险因素的关系
Clin Appl Thromb Hemost. 2005 Apr;11(2):147-59. doi: 10.1177/107602960501100204.
7
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.硫酸吲哚酚——一种将慢性肾病患者的止血系统紊乱与心血管疾病患病率联系起来的尿毒症毒素。
BMC Nephrol. 2017 Jan 25;18(1):35. doi: 10.1186/s12882-017-0457-1.
8
Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).血栓前状态与年龄增长的关系(来自弗雷明汉后代研究)
Am J Cardiol. 2005 Nov 1;96(9):1280-3. doi: 10.1016/j.amjcard.2005.06.072. Epub 2005 Sep 8.
9
Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.阵发性、持续性和永久性心房颤动患者血浆血管性血友病因子、纤维蛋白原及可溶性P选择素水平。心脏复律及左心房功能恢复的影响。
Eur Heart J. 2001 Sep;22(18):1741-7. doi: 10.1053/euhj.2000.2531.
10
Up to date concepts about Von Willebrand disease and the diagnose of this hemostatic disorder.关于血管性血友病及这种止血障碍性疾病诊断的最新概念。
J Med Life. 2014 Sep 15;7(3):327-34. Epub 2014 Sep 25.

本文引用的文献

1
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.经皮冠状动脉介入治疗后患者残余炎症风险与临床结局的影响。
Eur Heart J. 2018 Dec 7;39(46):4101-4108. doi: 10.1093/eurheartj/ehy633.
2
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.纤维蛋白凝块特性可独立预测急性冠脉综合征后的不良临床结局:一项 PLATO 亚研究。
Eur Heart J. 2018 Apr 1;39(13):1078-1085. doi: 10.1093/eurheartj/ehy013.
3
Novel Risk Markers and Risk Assessments for Cardiovascular Disease.心血管疾病的新型风险标志物和风险评估。
Circ Res. 2017 Jan 6;120(1):133-149. doi: 10.1161/CIRCRESAHA.116.309955.
4
High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction.高治疗期血小板反应性:急性心肌梗死患者的危险因素及5年预后
Anatol J Cardiol. 2017 Feb;17(2):113-118. doi: 10.14744/AnatolJCardiol.2016.7042. Epub 2016 Oct 5.
5
Inflammatory Contribution of Platelets Revisited: New Players in the Arena of Inflammation.血小板的炎症作用再探讨:炎症领域的新参与者
Semin Thromb Hemost. 2016 Apr;42(3):205-14. doi: 10.1055/s-0035-1570081. Epub 2016 Feb 17.
6
Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography.评估血栓弹力图和血栓弹性描记术中计算血小板对凝血强度贡献(血小板成分)的方法
Anesth Analg. 2015 Oct;121(4):868-878. doi: 10.1213/ANE.0000000000000859.
7
Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy.无药物血小板可在抗血小板治疗期间充当聚集体形成的种子。
Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2122-33. doi: 10.1161/ATVBAHA.115.306219. Epub 2015 Aug 13.
8
Antiplatelet drugs in patients with enhanced platelet turnover: biomarkers versus platelet function testing.血小板周转率增强患者的抗血小板药物:生物标志物与血小板功能检测
Thromb Haemost. 2015 Aug 31;114(3):459-68. doi: 10.1160/TH15-02-0179. Epub 2015 Aug 13.
9
Gradual increase in thrombogenicity of juvenile platelets formed upon offset of prasugrel medication.普拉格雷停药后形成的青少年血小板的血栓形成性逐渐增加。
Haematologica. 2015 Sep;100(9):1131-8. doi: 10.3324/haematol.2014.122457. Epub 2015 Jun 25.
10
Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients.肥胖患者全血血栓弹力图(ROTEM®)和阻抗法血小板聚集检测(MULTIPLATE®)发现的高凝状态。
Thromb Res. 2015 Mar;135(3):548-53. doi: 10.1016/j.thromres.2015.01.003. Epub 2015 Jan 7.